Rafferty Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.5M | Buy |
40,905
+11,877
| +41% | +$5.7M | 0.05% | 160 |
|
|
2026
Q1 | $14.3M | Sell |
29,028
-11,422
| -28% | -$6.2M | 0.06% | 190 |
|
|
2025
Q4 | $23.4M | Sell |
40,450
-1,476
| -4% | -$835K | 0.08% | 137 |
|
|
2025
Q3 | $20.3M | Buy |
41,926
+2,030
| +5% | +$945K | 0.07% | 159 |
|
|
2025
Q2 | $16.2M | Buy |
39,896
+4,480
| +13% | +$1.87M | 0.05% | 185 |
|
|
2025
Q1 | $17.6M | Sell |
35,416
-7,965
| -18% | -$4.31M | 0.08% | 159 |
|
|
2024
Q4 | $22.6M | Buy |
43,381
+4,636
| +12% | +$2.55M | 0.08% | 139 |
|
|
2024
Q3 | $24M | Sell |
38,745
-2,769
| -7% | -$1.64M | 0.08% | 131 |
|
|
2024
Q2 | $23M | Buy |
41,514
+1,639
| +4% | +$939K | 0.09% | 124 |
|
|
2024
Q1 | $23.2M | Buy |
39,875
+540
| +1% | +$303K | 0.09% | 126 |
|
|
2023
Q4 | $20.9M | Sell |
39,335
-934
| -2% | -$452K | 0.09% | 135 |
|
|
2023
Q3 | $20.4M | Buy |
40,269
+2,944
| +8% | +$1.57M | 0.12% | 114 |
|
|
2023
Q2 | $19.5M | Buy |
37,325
+2,230
| +6% | +$1.2M | 0.11% | 116 |
|
|
2023
Q1 | $20.2M | Buy |
35,095
+1,265
| +4% | +$713K | 0.14% | 108 |
|
|
2022
Q4 | $18.6M | Buy |
33,830
+12,788
| +61% | +$6.78M | 0.16% | 105 |
|
|
2022
Q3 | $10.7M | Buy |
21,042
+11,468
| +120% | +$6.42M | 0.11% | 137 |
|
|
2022
Q2 | $5.2M | Sell |
9,574
-2,555
| -21% | -$1.41M | 0.05% | 271 |
|
|
2022
Q1 | $7.16M | Sell |
12,129
-1,211
| -9% | -$696K | 0.04% | 263 |
|
|
2021
Q4 | $8.9M | Buy |
13,340
+797
| +6% | +$498K | 0.05% | 210 |
|
|
2021
Q3 | $7.17M | Buy |
12,543
+4,337
| +53% | +$2.38M | 0.05% | 228 |
|
|
2021
Q2 | $4.14M | Buy |
8,206
+666
| +9% | +$314K | 0.03% | 382 |
|
|
2021
Q1 | $3.44M | Buy |
7,540
+899
| +14% | +$429K | 0.02% | 398 |
|
|
2020
Q4 | $3.09M | Sell |
6,641
-524
| -7% | -$246K | 0.03% | 342 |
|
|
2020
Q3 | $3.16M | Sell |
7,165
-1,743
| -20% | -$720K | 0.04% | 271 |
|
|
2020
Q2 | $3.23M | Buy |
8,908
+5,823
| +189% | +$1.95M | 0.05% | 253 |
|
|
2020
Q1 | $875K | Sell |
3,085
-7,742
| -72% | -$2.44M | 0.04% | 254 |
|
|
2019
Q4 | $3.52M | Buy |
10,827
+10,103
| +1,395% | +$3.06M | 0.05% | 195 |
|
|
2019
Q3 | $211K | Hold |
724
| – | – | ﹤0.01% | 774 |
|
|
2019
Q2 | $213K | Sell |
724
-23
| -3% | -$6.33K | ﹤0.01% | 774 |
|
|
2019
Q1 | $204K | Buy |
+747
| New | +$186K | ﹤0.01% | 762 |
|
|
2018
Q2 | – | Sell |
-2,368
| Closed | -$489K | – | 702 |
|
|
2018
Q1 | $489K | Buy |
+2,368
| New | +$497K | 0.01% | 586 |
|
|
2016
Q3 | – | Sell |
-3,889
| Closed | -$575K | – | 532 |
|
|
2016
Q2 | $575K | Buy |
+3,889
| New | +$574K | 0.04% | 353 |
|
|
2016
Q1 | – | Sell |
-5,862
| Closed | -$832K | – | 571 |
|
|
2015
Q4 | $832K | Sell |
5,862
-1,669
| -22% | -$223K | 0.1% | 268 |
|
|
2015
Q3 | $921K | Sell |
7,531
-1,624
| -18% | -$212K | 0.07% | 219 |
|
|
2015
Q2 | $1.19M | Sell |
9,155
-1,740
| -16% | -$227K | 0.08% | 183 |
|
|
2015
Q1 | $1.46M | Buy |
+10,895
| New | +$1.4M | 0.11% | 162 |
|
Other funds holding TMO
Rafferty Asset Management's TMO Position: Q2 2026 in Review
Rafferty Asset Management increased its Thermo Fisher Scientific (TMO) stake by 41% in Q2 2026, buying an estimated $5.7M and bringing the position to 40,905 shares worth $20.5M. The position accounts for 0.05% of the portfolio, ranked #160.
Rafferty Asset Management first reported a position in TMO in Q1 2015 and has held it in 36 quarters since. The position peaked at $24M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Rafferty Asset Management held 40,905 shares of Thermo Fisher Scientific worth $20.5M as of Q2 2026.
- Rafferty Asset Management bought 11,877 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.7M.
- Thermo Fisher Scientific made up 0.05% of Rafferty Asset Management's portfolio in Q2 2026, its #160 holding.
- Rafferty Asset Management first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 36 quarters since.
- Rafferty Asset Management's Thermo Fisher Scientific position peaked at $24M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.